198211-79-9

Basic information

• Product Name: Boronic acid, (2-methoxy-4-methylphenyl)- (9CI)
• Synonyms: Boronic acid, (2-methoxy-4-methylphenyl)- (9CI)
• CAS NO: 198211-79-9
• Molecular Formula: C₈H₁₁BO₃
• Molecular Weight: 165.98214
• Product Categories: BORONICACID
• Mol File: 198211-79-9.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 330.9±52.0 °C(Predicted)
• Appearance: /
• Density: 1.14±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 8.87±0.58(Predicted)
• CAS DataBase Reference: Boronic acid, (2-methoxy-4-methylphenyl)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Boronic acid, (2-methoxy-4-methylphenyl)- (9CI)(198211-79-9)
• EPA Substance Registry System: Boronic acid, (2-methoxy-4-methylphenyl)- (9CI)(198211-79-9)

Safety Data

• Hazardous Substances Data: 198211-79-9(Hazardous Substances Data)

Usage

General Description

Boronic acid, (2-methoxy-4-methylphenyl)- (9CI), also known as 2-Methoxy-4-(methyl)phenylboronic acid, is a chemical compound with the molecular formula C8H11BO3. It is a boronic acid derivative that is commonly used in organic synthesis and medicinal chemistry. Boronic acid, (2-methoxy-4-methylphenyl)- (9CI) is often employed as a building block for the synthesis of various pharmaceuticals and agrochemicals. Boronic acids are known for their ability to form reversible covalent bonds with diols and are widely used in the field of drug discovery and development. The (2-methoxy-4-methylphenyl) substituents on the boron atom provide specific reactivity and properties that make this compound useful for a variety of applications in both research and industrial settings.

Upstream product

• 121-43-7 Trimethyl borate 
• 95740-49-1 1-bromo-2-methoxy-4-methylbenzene 
• 38512-82-2 3-methoxy-4-nitrotoluene 
• 39538-68-6 2-methoxy-4-methylaniline 
• 150-46-9 triethyl borate 
• 2835-98-5 2-Hydroxy-4-methylanilin 
• 186583-59-5 1-iodo-2-methoxy-4-methylbenzene 
• 35928-80-4 6-iodo-3-methyl-phenol 

Downstream Products

• 1379680-52-0 C₃₈H₃₂O₂P₂ 
• 1379680-53-1 C₃₈H₃₂P₂ 
• 1313377-81-9 2-[2-tert-butyl-7-(2-methoxy-4-methylphenyl)-5-methylpyrazolo[1,5-a]pyrimidin-6-yl]acetic acid 
• 1313377-82-0 2-[2-tert-butyl-7-(2-hydroxy-4-methylphenyl)-5-methylpyrazolo[1,5-a]pyrimidin-6-yl]acetic acid 
• 1619901-74-4 3-(2-methoxy-4-methylphenyl)-3-methylcyclohexanone 
• 1380434-33-2 2-ethyl-7-(2-methoxy-4-methylphenyl)-3-nitropyrazolo[1,5-a]pyridine 
• 1049801-57-1 9-(2-methoxy-4-methylphenyl)adenine 
• 1049801-65-1 1-(2-methoxy-4-methylphenyl)thymine 
• 1049801-61-7 1-(2-methoxy-4-methylphenyl)uracil 
• 1049801-56-0 1-(2-methoxy-4-methylphenyl)cytosine 

Relevant articles and documents

NOVEL ANTIVIRAL COMPOUNDS

The present invention relates to compounds of formula (A) as defined herein having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutical amount of such compounds, optionally combined with one or more other drugs having antiviral activity.

NOVEL VIRAL REPLICATION INHIBITORS

The present invention relates to a series of novel compounds having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutical amount of such compounds, optionally combined with one or more other drugs having antiviral activity.